
Augtyro(Repotrectinib)

Ayvakit(Avapritinib)

Balversa(Erdafitinib)

Braftovi(Encorafenib)

Caprelsa(Vandetnib)

Cardioxane(Dexrazoxane)

Cotellic(Cobimetinib)

Cosela(Trilaciclib)

Cytalux(Pofalacianine)

Datroway(Datopotamab deruxtecan)

Elahere(Mirvetuximab soravtansine-gynx)

Erivedge(Vismodegib)

Fotivda(Tivozanib)

Gavreto(Pralsetinib)

Imdelltra(Imdelltra)

Krazati(Adagrasib)

Libtayo(Cemiplimab-rwlc)

Lysodren(Mitotane)

Margenza(Margetuximab)

Mektovi(Binimetinib)

Nerlynx(Neratinib)

Odomzo(Sonidegib)

Orgovyx(Relugolix)

Orserdu(Elacestrant)

Ogsiveo(Nirogacestat)

Pemazyre(Pemigatinib)

Qinlock(Ripretinib)

Retevmo/Retsevmo(Selpercatinib)

Rozlytrek (Entrectinib)

Tabrecta(Capmatinib)

Tazverik(Tazemetostat)

Tivdak®(Tisotumab Vedotin-tftv)
![It is used to treat adults with breast cancer that has spread (metastasized) or cannot be removed by surgery, and have triple-negative breast cancer(mTNBC) (negative for estrogen and progesterone hormone receptors and HER2 [TNBC]) who have received at least 2 prior treatments, including at least one for metastatic disease or hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer patients who have previously received endocrine therapy and at least 2 additional treatments for metastatic disease.](images/Oncology/Trodelvy.jpg)
Trodelvy(Sacituzumab Govitecan-hziy)

Truqap(Capivasertib)

Torisel(Temsirolimus)

Talzenna(Talazoparib)

Verzenio(Abemaciclib)

Vyloy(Zolbetuximab)

Welireq(Belzutifan)

Zejula(Niraparib)

Zelboraf(Vemurafemnib)

Zepzelca(Lurbinectedin)